Resumen de acción VIRP
Virbac SA fabrica y vende una gama de productos y servicios para animales de compañía y de granja en Francia, Europa, América Latina, América del Norte, Asia, Pacífico y África y Oriente Medio.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
No se han detectado riesgos en VIRP a partir de nuestros controles de riesgos.
Competidores de Virbac SA
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | €357.00 |
| 52 Week High | €377.50 |
| 52 Week Low | €232.50 |
| Beta | 0.91 |
| 1 Month Change | 3.33% |
| 3 Month Change | 5.93% |
| 1 Year Change | 17.82% |
| 3 Year Change | 27.96% |
| 5 Year Change | 125.38% |
| Change since IPO | 2,805.27% |
Noticias y actualizaciones recientes
Here's What Analysts Are Forecasting For Virbac SA (EPA:VIRP) After Its Yearly Results
Mar 22
Is Virbac SA (EPA:VIRP) Trading At A 23% Discount?
Jan 18Recent updates
Here's What Analysts Are Forecasting For Virbac SA (EPA:VIRP) After Its Yearly Results
Mar 22Is Virbac SA (EPA:VIRP) Trading At A 23% Discount?
Jan 18Virbac SA's (EPA:VIRP) Shares Climb 25% But Its Business Is Yet to Catch Up
Dec 27Virbac (EPA:VIRP) Has A Pretty Healthy Balance Sheet
Oct 19Is There An Opportunity With Virbac SA's (EPA:VIRP) 40% Undervaluation?
Sep 26Here's Why We Think Virbac (EPA:VIRP) Is Well Worth Watching
Sep 05A Look At The Fair Value Of Virbac SA (EPA:VIRP)
Jun 20Does Virbac (EPA:VIRP) Deserve A Spot On Your Watchlist?
May 31Is Virbac (EPA:VIRP) Using Too Much Debt?
Apr 09Are Investors Undervaluing Virbac SA (EPA:VIRP) By 34%?
Feb 28Virbac SA (EPA:VIRP) Shares Could Be 50% Below Their Intrinsic Value Estimate
Nov 25Does Virbac (EPA:VIRP) Have A Healthy Balance Sheet?
Oct 14An Intrinsic Calculation For Virbac SA (EPA:VIRP) Suggests It's 42% Undervalued
Aug 07These 4 Measures Indicate That Virbac (EPA:VIRP) Is Using Debt Safely
Jun 26Virbac SA (EPA:VIRP) Shares Could Be 38% Below Their Intrinsic Value Estimate
May 01We Think Virbac (EPA:VIRP) Can Manage Its Debt With Ease
Mar 26Virbac SA (EPA:VIRP) Shares Could Be 36% Below Their Intrinsic Value Estimate
Jan 26Here's Why I Think Virbac (EPA:VIRP) Is An Interesting Stock
Dec 28A Look At The Fair Value Of Virbac SA (EPA:VIRP)
Oct 27Is Virbac (EPA:VIRP) Using Too Much Debt?
Oct 12Here's Why I Think Virbac (EPA:VIRP) Might Deserve Your Attention Today
Sep 26Is Virbac SA (EPA:VIRP) Trading At A 22% Discount?
Jul 15Is Now The Time To Put Virbac (EPA:VIRP) On Your Watchlist?
Jun 27Is Virbac (EPA:VIRP) A Risky Investment?
May 27Robust Earnings May Not Tell The Whole Story For Virbac (EPA:VIRP)
Mar 24Are Investors Undervaluing Virbac SA (EPA:VIRP) By 32%?
Mar 12Here's Why We Think Virbac (EPA:VIRP) Is Well Worth Watching
Feb 22Is Virbac SA (EPA:VIRP) Popular Amongst Insiders?
Feb 03
Virbac SA's (EPA:VIRP) Stock Is Going Strong: Is the Market Following Fundamentals?
Jan 05Does Virbac's (EPA:VIRP) Share Price Gain of 96% Match Its Business Performance?
Dec 18Estimating The Fair Value Of Virbac SA (EPA:VIRP)
Dec 01Here's Why I Think Virbac (EPA:VIRP) Might Deserve Your Attention Today
Nov 18Rentabilidad de los accionistas
| VIRP | FR Pharmaceuticals | Mercado FR | |
|---|---|---|---|
| 7D | -0.8% | -0.5% | -0.1% |
| 1Y | 17.8% | -14.0% | 1.3% |
Rentabilidad vs. Industria: VIRP superó al sector French Pharmaceuticals , que obtuvo un rendimiento del -2.8% el año pasado.
Rentabilidad vs. Mercado: VIRP superó al mercado French, que obtuvo un rendimiento del 3.7% el año pasado.
Volatilidad de los precios
| VIRP volatility | |
|---|---|
| VIRP Average Weekly Movement | 3.6% |
| Pharmaceuticals Industry Average Movement | 3.5% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in FR Market | 9.5% |
| 10% least volatile stocks in FR Market | 2.3% |
Precio estable de las acciones: VIRP no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de VIRP (4%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1968 | 5,459 | Sebastien Huron | corporate.virbac.com |
Virbac SA fabrica y vende una gama de productos y servicios para animales de compañía y de granja en Francia, Europa, Latinoamérica, Norteamérica, Asia, Pacífico y África y Oriente Medio. La empresa ofrece una gama de vacunas, productos de higiene dental, reproducción, dermatología, parasiticidas, diagnóstico, antibióticos y acuicultura; y medicamentos veterinarios para anestesia, geriatría, comportamiento y micronutrientes inyectables, así como alimentos para animales de compañía e identificación electrónica. Atiende a veterinarios, ganaderos y propietarios de animales de compañía.
Resumen de fundamentos de Virbac SA
| Estadísticas fundamentales de VIRP | |
|---|---|
| Capitalización bursátil | €2.99b |
| Beneficios(TTM) | €121.30m |
| Ingresos (TTM) | €1.25b |
24.6x
Ratio precio-beneficio (PE)2.4x
Ratio precio-ventas (PS)¿Está VIRP sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de VIRP | |
|---|---|
| Ingresos | €1.25b |
| Coste de los ingresos | €433.87m |
| Beneficio bruto | €813.03m |
| Otros gastos | €691.73m |
| Beneficios | €121.30m |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
Sep 13, 2024
| Beneficios por acción (BPA) | 14.49 |
| Margen bruto | 65.20% |
| Margen de beneficio neto | 9.73% |
| Ratio deuda/patrimonio | 9.6% |
¿Cómo se ha desempeñado VIRP a largo plazo?
Ver rendimiento histórico y comparativa